These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38619801)
1. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner. Zheng H; Cao Z; Lv Y; Cai X Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801 [TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms. He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192 [TBL] [Abstract][Full Text] [Related]
3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961 [TBL] [Abstract][Full Text] [Related]
4. FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas. Song T; Hu Z; Zeng C; Luo H; Liu J Heliyon; 2023 Jun; 9(6):e16280. PubMed ID: 37260902 [TBL] [Abstract][Full Text] [Related]
5. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner. Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z Genomics; 2023 Jan; ():110566. PubMed ID: 36690262 [TBL] [Abstract][Full Text] [Related]
6. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12. Sun Y; Liu Y; Wang P; Chang L; Huang J Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673 [TBL] [Abstract][Full Text] [Related]
7. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma. Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068 [TBL] [Abstract][Full Text] [Related]
8. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression. He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621 [TBL] [Abstract][Full Text] [Related]
9. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner. Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233 [TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207 [TBL] [Abstract][Full Text] [Related]
11. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells Dai X; Chen K; Xie Y Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586 [TBL] [Abstract][Full Text] [Related]
12. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability. Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860 [TBL] [Abstract][Full Text] [Related]
13. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation. Ma H; Shen L; Yang H; Gong H; Du X; Li J IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540 [TBL] [Abstract][Full Text] [Related]
14. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia. Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513 [TBL] [Abstract][Full Text] [Related]
15. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA. Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979 [TBL] [Abstract][Full Text] [Related]
16. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma. Rong L; Xu Y; Zhang K; Jin L; Liu X Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458 [TBL] [Abstract][Full Text] [Related]
17. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development. Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639 [TBL] [Abstract][Full Text] [Related]
18. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Jin W; Yao Y; Fu Y; Lei X; Fu W; Lu Q; Tong X; Xu Q; Su W; Hu X Cell Mol Biol Lett; 2024 Jul; 29(1):97. PubMed ID: 38961325 [TBL] [Abstract][Full Text] [Related]
19. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma. Wu W; Li M; Wu Y; Wei Q; Yu N Cell Death Discov; 2024 Aug; 10(1):361. PubMed ID: 39138186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]